Lonza | LONN - Gross Profit On Sales


Lonza reported CHF1.29B in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Akzo Nobel EUR 936M 102M Dec/2025
Alcon AG USD 1.69B 175M Mar/2026
Almirall EUR 429.87M 180.02M Dec/2025
AstraZeneca USD 12.61B 225M Mar/2026
BASF EUR 3.11B 55M Dec/2025
Bayer EUR 6.94B 1.58B Dec/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
Covestro EUR 212M 276M Dec/2025
Demant DKK 8.82B 277M Dec/2025
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.18B 210M Mar/2026
Geberit CHF 524.3M 125.1M Dec/2025
Genmab DKK 977M 13M Dec/2025
Givaudan CHF 1.55B 140M Dec/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
GN Store Nord DKK 2.5B 344M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Johnson Matthey GBP 480M 33M Jun/2024
Merck EUR 3.07B 104M Mar/2026
Novartis USD 10.07B 184M Mar/2026
Philips EUR 1.77B 522M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Sika AG CHF 3.02B 104.6M Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025
Solvay EUR 266M 31M Mar/2026
UCB EUR 3.19B 621M Dec/2025